Trial Details
COMPLETEDBasic Information
| Clinical ID | c799 |
|---|---|
| Identifier | NCT02818686 |
| Trial Title | TD-1473 for Active Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis, Active Moderate|Ulcerative Colitis, Active Severe |
| Interventions | DRUG: TD-1473|DRUG: Placebo |
Participant Information
| Sponsor | Theravance Biopharma |
|---|---|
| City | Scottsdale |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2016-10-03 |
|---|---|
| Primary Completion Date | 2018-03-29 |
| Completion Date | 2018-03-29 |